ANGO Past Earnings image   This ANGO past earnings page last updated 6/16/2022
ANGO Past Earnings
PeriodPast Earnings DateAdj. EPS
Q3 20224/7/20220.030
Q2 20221/6/2022-0.020
Q1 20229/30/2021-0.020
Q4 20217/13/20210.000
Q3 20213/30/20210.020
Q2 20211/7/20210.010
Q1 20219/29/20200.020
Q4 20207/16/2020-0.060
Q3 20204/7/20200.010
Q2 20201/7/20200.060
Q1 202010/3/20190.080
Q4 20197/10/20190.250
Q3 20194/2/20190.19
Q2 20191/4/20190.22
Q1 20199/27/20180.16
Q4 20187/11/20180.2
Q3 20183/29/20180.25
Q2 20181/4/20180.16
Q1 20189/28/20170.12
Q4 20177/18/20170.19
Q3 20173/30/20170.19
Q2 20171/6/20170.19
Q1 201710/5/20160.17
Q4 20167/13/20160.19
Q3 20164/7/20160.15
Q2 20161/7/20160.14
Q1 201610/8/20150.11
Q4 20157/16/20150.14
Q3 20154/9/20150.12
Q2 20151/8/20150.17
Q1 201510/9/20140.16
Q4 20147/23/20140.18
Q3 20144/9/20140.16
Q2 20141/9/20140.14
Q1 201410/10/20130.04
Q4 20137/11/20130.07
Q3 20134/8/20130.08
Q2 20131/3/20130.1
Q1 201310/8/20120.1
Q4 20127/12/20120.11
ANGO Past Revenue
PeriodPast Earnings DateGAAP
Q3 20224/7/20220.07B
Q2 20221/6/20220.08B
Q1 20229/30/20210.08B
Q4 20217/13/20210.08B
Q3 20213/30/20210.07B
Q2 20211/7/20210.07B
Q1 20219/29/20200.07B
Q4 20207/16/20200.06B
Q3 20204/7/20200.07B
Q2 20201/7/20200.07B
Q1 202010/3/20190.07B
Q4 20197/10/20190.10B
Q3 20194/2/201986.34M
Q2 20191/4/201991.50M
Q1 20199/27/201885.34M
Q4 20187/11/201888.32M
Q3 20183/29/201883.85M
Q2 20181/4/201886.71M
Q1 20189/28/201785.41M
Q4 20177/18/201786.91M
Q3 20173/30/201785.60M
Q2 20171/6/201789.03M
Q1 201710/5/201688.10M
Q4 20167/13/201693.37M
Q3 20164/7/201687.38M
Q2 20161/7/201689.23M
Q1 201610/8/201583.70M
Q4 20157/16/201590.90M
Q3 20154/9/201586.60M
Q2 20151/8/201592.10M
Q1 201510/9/201487.30M
Q4 20147/23/201494.10M
Q3 20144/9/201488.20M
Q2 20141/9/201488.60M
Q1 201410/10/201383.60M
Q4 20137/11/201390.00M
Q3 20134/8/201381.60M
Q2 20131/3/201387.00M
Q1 201310/8/201283.40M
Q4 20127/12/20120.06B
Quotes delayed 20 minutes

Email EnvelopeFree ANGO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
AngioDynamics (ANGO) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ANIK Historical Earnings
ANIP Historical Earnings
ANIX Historical Earnings
ANNX Historical Earnings
ANVS Historical Earnings
APDN Historical Earnings
APEN Historical Earnings
APLS Historical Earnings
APLT Historical Earnings
APR Historical Earnings

ANGO Past Earnings Q&A

What was the best and worst ANGO past earnings results?
For AngioDynamics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest ANGO past earnings result in our data set was 0.250/share posted in Q4 2019, while the lowest was in Q4 2020 when ANGO posted -0.060/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2019 when ANGO reported 0.10B in revenue, while the quarter with the lowest revenue in our data set was Q4 2012 at 0.06B of revenue.

  Suggested answer: There are 40 ANGO past earnings results in our data set.

On this page we presented the ANGO past earnings date information for AngioDynamics. Reviewing that ANGO Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2019, when ANGO posted adjusted EPS of 0.250/share. Meanwhile the lowest ANGO past earnings result was in Q4 2020, when ANGO posted adjusted EPS of -0.060/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2019 when ANGO reported 0.10B in revenue, while the smallest revenue quarter was Q4 2012 when ANGO reported 0.06B in revenue.

Any self directed investor doing their due diligence on ANGO or any other given stock can benefit from researching all of the AngioDynamics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate AngioDynamics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for ANGO. Thanks for visiting, and the next time you need to research ANGO past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: USPH Dividend History, FLY Options Chain, GPC Stock Predictions.

 

ANGO Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.